Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

910

Participants

Timeline

Start Date

December 31, 1994

Study Completion Date

March 31, 2002

Conditions
ThrombosisThromboembolismVenous Thrombosis
Interventions
DRUG

Tinzaparin sodium

Trial Locations (1)

T2N 2T9

Thrombosis Research Unit, University of Calgary, Calgary

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

LEO Pharma

INDUSTRY

collaborator

Dupont Applied Biosciences

INDUSTRY

lead

University of Calgary

OTHER